Brief reportPrethrombolytic versus thrombolytic era risk stratification of patients with acute myocardial infarction
References (19)
- et al.
Predictors of in-hospital and 6-month outcome after acute myocardial infarction in the reperfusion era: the Primary Angioplasty in Myocardial Infarction (PAMI) Trial
J Am Coll Cardiol
(1995) - et al.
The effect of diabetes mellitus on prognosis and serial left ventricular function after acute myocardial infarction: contribution of both coronary disease and diastolic left ventricular dysfunction on adverse prognosis
J Am Coll Cardiol
(1989) - et al.
Risk stratification after acute myocardial infarction
Am J Cardiol
(1978) - et al.
Differential risk patterns associated with 3 month as compared with 3 to 12 month mortality and rein-farction after non-Q wave myocardial infarction
J Am Coll Cardiol
(1990) - et al.
Characteristics associated with early (≤3 months) versus late (>3 months to ≤3 years) mortality after acute myocardial infarction
Am J Cardiol
(1989) Halving of mortality at 1 year by domiciliary thrombolysis in the Grampian Region Early Anistreplase Trial (GREAT)
J Am Coll Cardiol
(1994)Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction
Lancet
(1986)- et al.
Prognostic significance of the extent of myocardial injury in acute myocardial infarction treated by streptokinase (the GISSI trial)
Am J Cardiol
(1989) - et al.
Randomized comparison of rescue angioplasty with conservative management of patients with early failure of thrombolysis for acute anterior myocardial infarction
Circulation
(1994)
There are more references available in the full text version of this article.
Cited by (9)
Mortality of myocardial infarction in the PRIMVAC registry. Prognostic factors
2004, Medicina ClinicaClinical prediction of short-term prognosis in acute myocardial infarction
1997, Revista Espanola de CardiologiaDiabetes Mellitus and Acute Myocardial Infarction: Impact on Short and Long-Term Mortality
2021, Advances in Experimental Medicine and BiologyThe Evaluation of Cardiac and Peripheral Arterial Disease in Patients with Diabetes Mellitus
2016, Type 2 Diabetes: Principles and Practice, Second EditionThe evaluation of cardiac and peripheral arterial disease in patients with diabetes mellitus
2007, Endocrine ResearchImpact of diabetes on mortality in patients with myocardial infarction and left ventricular dysfunction
2004, Archives of Internal Medicine
- a
Dr. Murphy is a training fellow of the National Heart, Lung, and Blood Institute, and is supported by Grant 5-T32-HL07081-19, Bethesda, Maryland.
- b
Dr. Kahn is supported in part by Grants U01-LM05845 and R29-LM05387 from the National Library of Medicine.
- c
Dr. Murphy's address is: Cardiovascular Division, Washington University School of Medicine, Box 8086, 660 South Euclid Avenue, St. Louis, Missouri 63110.
Copyright © 1995 Published by Elsevier Inc.